Thyroid · 2001 · 38 citations · 19 references
MedicineGeneticsMolecular GeneticsCancer GeneticsMetastasisMolecular OncologyEndocrine Tumor GeneticsRadioiodine TherapyThyroid CancerThyroid DisordersThyroid EndocrinologyDirect Rna SequencingIodide UptakeMetastatic Thyroid Tissue DetectionMetastatic Tumors To The ThyroidPoint MutationsProtein Expression LevelsThyroid Cancer GeneticsTranscripts
Decrease or loss of the sodium iodide (Na+/I-) symporter (NIS) activity influences the suitability of using radioiodine to detect and treat metastatic thyroid tissues. In previous studies, the presence of the NIS transcript, albeit at lower expression levels, has been shown in most thyroid differentiated carcinomas. In this study we searched for point mutations or other genetic alterations that may be responsible for an altered function of the NIS protein in tumors that still express NIS transcripts. Tumoral cDNAs derived from seven differentiated thyroid carcinomas (DTC), five papillary and two follicular, were analyzed by direct sequencing after polymerase chain reaction (PCR) amplification of the structural gene of the Na+/I- symporter. Neither mutations nor other genetic abnormalities were detected in any tumor sample examined. The data indicate that mutations or other genetic alterations of the NIS structural gene are not a major cause of the reduced iodide uptake in DTC.
19
Cloning and characterization of the thyroid iodide transporter
Ge Dai, Orlie Levy, Nancy Carrasco · Nature · 1996 · 1.1K citations
Vladimir Lazar, Jean-Michel Bidart, Bernard Caillou et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 299 citations · Full text